SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4374Been meaning to look it up myself. Showed up as a new investment in MPM's rkeokalani'nui6/10/2005
4373Celldex Therapeutics Sets IPO At 4M Shrs, $8-$10/Shr DOW JONES NEWSWIRES June 8mopgcw6/10/2005
4372Pardon my rudeness, you have an interesting profile. Distressed assets? Workouttom pope6/9/2005
4371Anybody have any thoughts on FVRL?Bernard Guerrero6/9/2005
4370thanks, Tuck!! Rickscaram(o)uche6/9/2005
4369Latest moves from BVF, for those interested: buying a 5.1% stake in Corgentech tuck6/9/2005
4368Icahn May Buy More of ImClone By GEETA ANAND Staff Reporter of THE WALL STREETDoc Bones6/8/2005
4367>>CAMBRIDGE, Mass., June 7 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticaltuck6/7/2005
4366Signals on big pharma's need for inlicensing deals from biotechs: signalsmatuck6/7/2005
4365Somaxon Pharmaceuticals, Inc. Announces $65 Million Financing Monday June 6, 8:0nigel bates6/6/2005
4364The long-needed "post-IPO" rescue funding came recently to Acadia. Thscaram(o)uche6/5/2005
4363Rather unusual, stock price rose from ~$9 to $10/share AFTER announcement of equExtra Pale6/4/2005
4362Drug-maker XenoPort lowers price to $10.50 XenoPort, a developer of oral versionsjemmeri6/2/2005
4361much drama across the pond this week-g-zeta19616/1/2005
4360and, in any event..... isn't the entire 45 billion just XOMA alone?? ;-)scaram(o)uche6/1/2005
4359Board fight at Flamel.... Press Release Source: Flamel Technologies Flamel Terkrw6/1/2005
4358There's a good job waiting for us at Wal-Mart. They'll make sure we canDoc Bones6/1/2005
4357There's tons of crappy research....... wasted dollars, garbage companies scaram(o)uche6/1/2005
4356>>Biotech's Hype and Hope Yielded Losses Wednesday June 1, 1:06 am ET tuck6/1/2005
4355Product Success and Strong Financials Drive Biotech Industry's Maturation Acscaram(o)uche6/1/2005
4354BioMarin Announces FDA Approval for Naglazyme Wednesday June 1, 12:30 am ET Fiscaram(o)uche6/1/2005
4353Biotech firm Hemosense revises its IPO terms Hemosense, a developer of handheld sjemmeri5/31/2005
4352vrtx, some badly needed balance sheet repair. Vertex Pharmaceuticals Announces keokalani'nui5/31/2005
4351Preliminary Phase I/II Data Show Lucentis(TM) in Combination With Visudyne(R) Mascaram(o)uche5/31/2005
4350Hybridon Announces $5 Million Private Financing CAMBRIDGE, Mass., May 20, 2005 –sjemmeri5/25/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):